Showing items 1–100
METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDER
Application WO-2023214189-A1
World Intellectual Property Organisation (WIPO)
Nanoscale process to generate reagents selective for individual protein variants
Grant US-RE49625-E1
United States of America
Isoindoline compositions and methods for treating neurodegenerative disease
Grant US-11691947-B2
United States of America
PROTEINS AND PROTEIN LIBRARIES
Application WO-2023079185-A1
World Intellectual Property Organisation (WIPO)
MAP kinase modulators and uses thereof
Grant US-11566016-B2
United States of America
MODULATORS OF PrPC AND USES THEREOF
Application WO-2022243549-A1
World Intellectual Property Organisation (WIPO)
MODULATORI DI PrPC E LORO USI
N/A IT-202100013244-A1
Italy
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
Application EP-4023294-A1
European Patent Office
Antibodies to amyloid beta
Grant US-11286297-B2
United States of America
Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
Grant US-11241450-B2
United States of America
Compositions for treating neurodegenerative diseases
Grant US-11214540-B2
United States of America
Histone acetyltransferase activators and uses thereof
Grant US-11191768-B2
United States of America
MAP kinase modulators and uses thereof
Grant US-11149020-B2
United States of America
Uridine nucleoside derivatives, compositions and methods of use
Grant US-11124536-B2
United States of America
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative…
Grant US-11072627-B2
United States of America
Histone acetyltransferase activators and uses thereof
Grant US-11034647-B2
United States of America
DETECTION OF A-BETA OLIGOMERS
Application WO-2021032966-A1
World Intellectual Property Organisation (WIPO)
Phosphodiesterase inhibitors and uses thereof
Grant US-10899756-B2
United States of America
Anti-PrP antibodies and uses thereof
Grant US-10808034-B2
United States of America
ANTIBODIES TO AMYLOID BETA
Application EP-3721942-A1
European Patent Office
Antibodies to amyloid beta
Grant US-10662239-B2
United States of America
Histone acetyltransferase activators and uses thereof
Grant US-10640457-B2
United States of America
Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
Grant US-10632138-B2
United States of America
Phosphodiesterase inhibitors and uses thereof
Grant US-10626113-B2
United States of America
HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
Application EP-3632901-A1
European Patent Office
Isoindoline compositions and methods for treating neurodegenerative disease
Grant US-10611728-B2
United States of America
AMYLOSPHEROID (ASPD)-LIKE STRUCTURE AND PHARMACEUTICAL COMPOSITION
Application EP-3444344-A4
European Patent Office
Uridine nucleoside derivatives, compositions and methods of use
Grant US-10544183-B2
United States of America
MAP kinase modulators and uses thereof
Application US-10428047-B2
United States of America
PYRAZINE COMPOUNDS AS MAP KINASE MODULATORS AND USES THEREOF
Application EP-3521284-A1
European Patent Office
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
Application EP-3498692-A1
European Patent Office
Isoindoline compositions and methods for treating neurodegenerative disease
Grant US-10207991-B2
United States of America
Uridine nucleoside derivatives, compositions and methods of use
Grant US-10138265-B2
United States of America
Phosphodiesterase inhibitors and uses thereof
Grant US-9974782-B2
United States of America
Histone acetyltransferase modulators and uses thereof
Grant US-9969677-B2
United States of America
Nanoscale process to generate reagents selective for individual protein variants
Grant US-9938330-B2
United States of America
Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
Grant US-9913855-B2
United States of America
CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST OLIGOMERS OF AMYLOID BETA
Application EP-3269736-A1
European Patent Office
Oligomer-specific amyloid beta epitope and antibodies
Application US-9849165-B2
United States of America
Methods of preventing, treating, and diagnosing disorders of protein aggregation
Grant US-9833420-B2
United States of America
Antibodies to amyloid beta
Grant US-9834598-B2
United States of America
Inhibitors of cognitive decline
Grant US-9815770-B2
United States of America
Isoindoline compositions and methods for treating neurodegenerative disease
Grant US-9796672-B2
United States of America
AMYLOSPHEROID (ASPD)-LIKE STRUCTURE AND PHARMACEUTICAL COMPOSITION
Application WO-2017179646-A1
World Intellectual Property Organisation (WIPO)
Map kinase modulators and uses thereof
Application US-9783525-B2
United States of America
Uridine diphosphate derivatives, prodrugs, compositions and methods for treating…
Grant US-9750760-B2
United States of America
Immunotherapy regimes dependent on ApoE status
Grant US-9644025-B2
United States of America
EphA4 inhibitors as neuroprotective agents
Grant US-9629830-B2
United States of America
Conformational-specific antibodies against A[β] oligomers
Grant US-9617332-B2
United States of America
Polynucleotides encoding anti-amyloid beta monoclonal antibodies
Grant US-9585956-B2
United States of America
Aβ protofibril binding antibodies
Grant US-9573994-B2
United States of America
Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid
Grant US-9567393-B2
United States of America
Isolated compounds from turmeric oil and methods of use
Grant US-9499462-B2
United States of America
A peptide or collection of peptides derived from amyloid precursor protein
Application EP-3070096-A1
European Patent Office
Phosphodiesterase inhibitors and uses thereof
Grant US-9422242-B2
United States of America
OLIGOMER-SPECIFIC AMYLOID BETA EPITOPE AND ANTIBODIES
Application EP-3056510-A1
European Patent Office
Methods of treating ocular disease associated with amyloid-beta-related pathology using…
Grant US-9403902-B2
United States of America
Inhibitors of cognitive decline
Grant US-9365491-B2
United States of America
Immunization with amyloid-beta oligomers
Grant US-9340606-B2
United States of America
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative…
Grant US-9227993-B2
United States of America
Methods for identifying safe and functional humanized antibodies
Grant US-9221900-B2
United States of America
Oligomer-specific amyloid beta epitope and antibodies
Application US-9216217-B2
United States of America
Prion protein as a receptor for amyloid-β oligomers
Application US-9217036-B2
United States of America
ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
Grant US-9217024-B2
United States of America
Inhibitors of cognitive decline
Grant US-9192585-B2
United States of America
Therapeutic curcumin derivatives
Grant US-9187397-B2
United States of America
Monoclonal antibody
Grant US-9175094-B2
United States of America
Methods for treating glaucoma using uridine diphosphate derivatives
Grant US-9163055-B2
United States of America
Polynucleotides encoding an anti-beta-amyloid monoclonal antibody
Grant US-9146244-B2
United States of America
Antibody treatment of Alzheimer's and related diseases
Grant US-9133267-B2
United States of America
ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
Application WO-2015116923-A1
World Intellectual Property Organisation (WIPO)
Hybrid amyloid-beta antibodies
Grant US-9067981-B1
United States of America
Use of GIP for the treatment of disorders associated with dysfunctional synaptic…
Grant US-9062125-B2
United States of America
Humanized antibodies that recognize beta amyloid peptide
Grant US-9051363-B2
United States of America
Protofibril selective antibodies and the use thereof
Grant US-9034334-B2
United States of America
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
Grant US-8999936-B2
United States of America
EphA4 INHIBITORS AS NEUROPROTECTIVE AGENTS
Application WO-2015007222-A1
World Intellectual Property Organisation (WIPO)
Humanized Aβ antibodies for use in improving cognition
Grant US-8916165-B2
United States of America
Use of selenium compounds, especially selenium yeasts for altering cognitive function
Grant US-8871715-B2
United States of America
Methods and compositions for altering cell function
Grant US-8865763-B2
United States of America
Method for preventing, treating and diagnosing disorders of protein aggregation
Grant US-8859628-B2
United States of America
Therapeutic curcumin derivatives
Grant US-8841326-B2
United States of America
Nucleic acid molecules encoding a humanized antibody
Grant US-8796439-B2
United States of America
Treatment of amyloidogenic diseases
Grant US-8784810-B2
United States of America
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative…
Grant US-8785620-B2
United States of America
Inhibitors of cognitive decline
Grant US-8765816-B2
United States of America
ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU
Application WO-2014059442-A2
World Intellectual Property Organisation (WIPO)
Prevention and treatment of amyloidogenic disease
Grant US-8642044-B2
United States of America
Composition comprising VLP and amyloid beta peptide
Grant US-8617566-B2
United States of America
Bispecific nanobodies as a therapeutic for alzheimer's disease
Grant US-8617549-B2
United States of America
Monoclonal antibody
Grant US-8613923-B2
United States of America
Treatment of amyloidogenic diseases
Grant US-8613920-B2
United States of America
Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative…
Grant US-8598141-B2
United States of America
CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST Αβ OLIGOMERS
Application WO-2013167681-A1
World Intellectual Property Organisation (WIPO)
Pharmaceutical composition for preventing or treating diseases associated with beta-amyloid…
Grant US-8536178-B2
United States of America
Prevention and treatment of amyloidogenic disease
Grant US-8535673-B2
United States of America
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
Grant US-8513253-B2
United States of America
Composition comprising VLP and amyloid beta peptide
Grant US-8460676-B2
United States of America
COMPOSITIONS FOR BINDING TO AMYLOID PROTEINS
Application WO-2013054110-A2
World Intellectual Property Organisation (WIPO)
Showing items 1–100